| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/05/2009 | US20090035279 Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma |
| 02/05/2009 | US20090035278 Reoviruses having modified sequences |
| 02/05/2009 | US20090035276 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 02/05/2009 | US20090035275 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of NAD |
| 02/05/2009 | US20090035274 Treatment and/or prevention of cancer and/or arthritis |
| 02/05/2009 | US20090035269 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | US20090035256 Modified interleukin 10 polypeptide for use in treatment and prevention of neuropathic pain, neurological and inflammatory disorders |
| 02/05/2009 | US20090035251 Method of applying an injectable filler |
| 02/05/2009 | CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2695398A1 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound |
| 02/05/2009 | CA2695256A1 Stem cells derived from the carotid body and uses thereof |
| 02/05/2009 | CA2694169A1 Pathogen inactivation of whole blood |
| 02/05/2009 | CA2690610A1 Method of constructing masses of myocardial cells and use of the myocardial cell mass |
| 02/05/2009 | CA2663034A1 Oncolytic rhabdovirus |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2019863A1 High-titer retroviral packaging cells |
| 02/04/2009 | EP2019861A2 Kidney-derived stem cell population, identification and therapeutic use |
| 02/04/2009 | EP2019682A1 Cytokine mediating composition |
| 02/04/2009 | EP2019680A1 Augmentation of titer for vaccination in animals |
| 02/04/2009 | EP1654015B1 Decellularized bone marrow extracellular matrix |
| 02/04/2009 | EP1587515A4 Biologic skin repair and enhancement |
| 02/04/2009 | CN201189318Y Device for producing sterile blood serum using four grade filtration membrane |
| 02/04/2009 | CN101360829A Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide |
| 02/04/2009 | CN101360512A Food products comprising probiotic micro-organisms and antibodies |
| 02/04/2009 | CN101360489A Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 02/04/2009 | CN101357229A Production technique of immunoglobulin compounding agent capable of preventing and treating pig diarrhea |
| 02/04/2009 | CN101357225A Preparation method of medicine for treating elderly cerebral dysfunction |
| 02/04/2009 | CN101357218A Externally used medicine for treating diabetes and preparation method thereof |
| 02/04/2009 | CN101357216A Production method of Jinggandu oral liquid |
| 02/04/2009 | CN101357215A Medicine combination for treating viral hepatitis and quality control method thereof |
| 02/04/2009 | CN101357214A Compound cantharis drop pill and preparation method thereof |
| 02/04/2009 | CN101357213A Compound cantharis liquid formulation and preparation method thereof |
| 02/04/2009 | CN101357212A Compound cantharis injection and preparation method thereof |
| 02/04/2009 | CN101357211A Traditional Chinese medicine navel paste for treating hepatocirrhosis endotoxemia and preparation method thereof |
| 02/04/2009 | CN101357208A Traditional Chinese medicine composition for treating chronic superficial gastritis |
| 02/04/2009 | CN101357206A Medicine for treating liver cancer and preparation method thereof |
| 02/04/2009 | CN101357205A Toxin elimination and clot absorbing traditional Chinese medicine and preparation method thereof |
| 02/04/2009 | CN101357203A Preparation for treating cancer and carcinoma and preparation method thereof |
| 02/04/2009 | CN101357202A Chinese traditional medicine for treating hepatosis and preparation method thereof |
| 02/04/2009 | CN101357201A Multipurpose traditional Chinese medicine and preparation method thereof |
| 02/04/2009 | CN101357198A Traditional Chinese medicine for treating cerebral thrombus |
| 02/04/2009 | CN101357197A Naozhengzhu Duoyuanqu totipotence biological activity traditional Chinese medicine preparation |
| 02/04/2009 | CN101357196A Super high biomass omnipotent ordered high activity polymer biological activity traditional Chinese medicine preparation series |
| 02/04/2009 | CN101357190A Traditional Chinese medicine composition for treating skin disease and preparation method thereof |
| 02/04/2009 | CN101357189A Traditional Chinese medicine composition for treating atrophic gastritis |
| 02/04/2009 | CN101357187A Medicine for treating the prostatitis |
| 02/04/2009 | CN101357186A Preparation method of medicine for treating the prostatitis |
| 02/04/2009 | CN101357177A Traditional Chinese medicine for preventing and treating central serous chorioretinopathy and preparation method thereof |
| 02/04/2009 | CN101357172A External traditional Chinese medicine for treating hyperosteogeny, urgent lumbar sprain, joint bursitis |
| 02/04/2009 | CN101357169A Medicine for quickly treating snake bite |
| 02/04/2009 | CN101357168A Medicinal wine for treating rheumatic arthritis |
| 02/04/2009 | CN101357162A Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis |
| 02/04/2009 | CN101357159A Shiji powder for preventing and treating taura syndrome virus and preparation method thereof |
| 02/04/2009 | CN101357156A Traditional Chinese medicine for curing diabetes and preparation method thereof |
| 02/04/2009 | CN101357155A Medicine for treating apoplexy |
| 02/04/2009 | CN101357148A Ginseng-pearl formulation and preparation method thereof |
| 02/04/2009 | CN101357143A Probiotics powder composition and product thereof |
| 02/04/2009 | CN101357142A Use of Clostridium butyricum in preparing medicine composition for preventing and treating cerebrovascular disease |
| 02/04/2009 | CN101357141A Water-soluble mixing active pearl calcium and preparation method thereof |
| 02/04/2009 | CN101357140A Vitamin-adding high-peptide pearl active calcium replenishing agent and preparation method thereof |
| 02/04/2009 | CN101357139A Multivitamin selenium-enriched active pearl oral preparation and preparation method thereof |
| 02/04/2009 | CN101356980A Preparation method of fish liver hydrolysate and use thereof |
| 02/04/2009 | CN100457178C Process for preparing bone peptide injection |
| 02/04/2009 | CN100457173C Medicine for treating disease due to kidney yang vacuity |
| 02/04/2009 | CN100457172C A Chinese traditional medicine for treatment of hepatitis and its preparation methods |
| 02/04/2009 | CN100457171C A preparation method of medicine for treating hemiparalysis caused by apoplexy |
| 02/04/2009 | CN100457167C Externally used traditional Chinese medicine preparation for treating nasal mucosa erosion and nosebleed and its preparation method |
| 02/04/2009 | CN100457161C Medicament for treating protrusion of ntervertebral disc and hyperosteogeny and preparation process thereof |
| 02/04/2009 | CN100457160C Medicine for curing cervical vertebra and its preparation |
| 02/04/2009 | CN100457155C Medicine for treating burn and scald |
| 02/04/2009 | CN100457150C Capsule or tablet for relieving vision fatigue and preparing method |
| 02/04/2009 | CN100457146C Capsule with diuresis promoting function containing amber and toad |
| 02/04/2009 | CN100457145C Chinese medicine composition for treating renal failure and its preparing method and use |
| 02/04/2009 | CN100457136C Chinese medicine for preventing from subcutaneous hemorrhage after pulling out needle |
| 02/04/2009 | CN100457135C Chinese medicinal composition for regulating male sexual function |
| 02/04/2009 | CN100457126C Composition of ephedra total alkaloid and earthworm acid part and preparation method thereof |
| 02/04/2009 | CN100457123C Calmophil, pharmaceutical composition for treating pulmonary surfactant system disorder and producing method thereof |
| 02/04/2009 | CN100457092C Drop pills for treating inflammation and preparation thereof |
| 02/04/2009 | CN100457089C Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 02/04/2009 | CN100456999C Silkworm excrement medicinal health care silk quilt |
| 02/04/2009 | CN100456942C Restorative tea of clearing fat |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485457 Cells can be used as minipumps to release serotonin and/or GABA; nervous system or neurodegenerative disorders; pain and spasticity treatment from brain and spinal cord injuries; antiepileptic and antidepressant agents; Alzheimer's and Parkinson's disease; gene expression |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | US7485292 Administering echovirus which recognizes integrin alpha 2 beta 1 for infectivity of the cells such that at least one of the cells are killed by the virus, wherein the abnormal cell is a cancer cell expressing alpha 2 beta 1; screening viruses |
| 02/03/2009 | US7485290 bacteria belongs to the genus Megasphaera or Mitsuokella |
| 02/03/2009 | CA2286165C A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 02/03/2009 | CA1341590C Human immune interferon |
| 02/01/2009 | CA2595744A1 Method of providing readily available cellular material derived from cord blood, and a composition thereof |
| 01/29/2009 | WO2009015343A2 Differentiation of multi-lineage progenitor cells to chondrocytes |
| 01/29/2009 | WO2009015186A2 Articles and methods for repairing damaged nervous tissue |
| 01/29/2009 | WO2009014919A2 H2n3 influenza a viruses and methods of use |
| 01/29/2009 | WO2009014708A2 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| 01/29/2009 | WO2009014668A2 Methods for promoting hair growth |
| 01/29/2009 | WO2009014456A1 Materials and methods for sperm sex selection |
| 01/29/2009 | WO2009014421A1 Probiotics for inducing satiety and/or satiation |
| 01/29/2009 | WO2009014411A1 Drug that can reduce cholesterol and urea levels and stabilise glucose, creatinine and triglyceride levels, prepared from eisenia foetida |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |